303 related articles for article (PubMed ID: 12492199)
1. Small intestinal glucose absorption and duodenal motility in type 1 diabetes mellitus.
Rayner CK; Schwartz MP; van Dam PS; Renooij W; de Smet M; Horowitz M; Smout AJ; Samsom M
Am J Gastroenterol; 2002 Dec; 97(12):3123-30. PubMed ID: 12492199
[TBL] [Abstract][Full Text] [Related]
2. Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release.
Chaikomin R; Wu KL; Doran S; Jones KL; Smout AJ; Renooij W; Holloway RH; Meyer JH; Horowitz M; Rayner CK
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1099-104. PubMed ID: 17204542
[TBL] [Abstract][Full Text] [Related]
3. Effects of metoclopramide on duodenal motility and flow events, glucose absorption, and incretin hormone release in response to intraduodenal glucose infusion.
Kuo P; Bellon M; Wishart J; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
Am J Physiol Gastrointest Liver Physiol; 2010 Dec; 299(6):G1326-33. PubMed ID: 20829521
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of small intestinal burst activity in the postprandial state differentially affects lipid and glucose absorption in healthy adult humans.
Bryant LK; Fraser RJ; Vozzo R; Zacharakis B; Matthews GM; Butler R
Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1028-34. PubMed ID: 15191881
[TBL] [Abstract][Full Text] [Related]
5. The stimulation of antral motility by erythromycin is attenuated by hyperglycemia.
Rayner CK; Su YC; Doran SM; Jones KL; Malbert CH; Horowitz M
Am J Gastroenterol; 2000 Sep; 95(9):2233-41. PubMed ID: 11007223
[TBL] [Abstract][Full Text] [Related]
6. Effects of physiological hyperglycemia on duodenal motility and flow events, glucose absorption, and incretin secretion in healthy humans.
Kuo P; Wishart JM; Bellon M; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
J Clin Endocrinol Metab; 2010 Aug; 95(8):3893-900. PubMed ID: 20501683
[TBL] [Abstract][Full Text] [Related]
7. Small bowel motility affects glucose absorption in a healthy man.
Schwartz MP; Samsom M; Renooij W; van Steenderen LW; Benninga MA; van Geenen EJ; van Herwaarden MA; de Smet MB; Smout AJ
Diabetes Care; 2002 Oct; 25(10):1857-61. PubMed ID: 12351491
[TBL] [Abstract][Full Text] [Related]
8. Effects of intraluminal local anesthetic on upper gastrointestinal motor, sensory, and peptide hormone responses to intraduodenal glucose.
Chaikomin R; Jones KL; Feinle-Bisset C; Meyer JH; Horowitz M; Rayner CK
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):258-65. PubMed ID: 19279470
[TBL] [Abstract][Full Text] [Related]
9. Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: A randomised controlled trial.
Thazhath SS; Wu T; Bound MJ; Checklin HL; Standfield S; Jones KL; Horowitz M; Rayner CK
Nutrition; 2016 May; 32(5):553-9. PubMed ID: 26792024
[TBL] [Abstract][Full Text] [Related]
10. Role of 5-hydroxytryptamine mechanisms in mediating the effects of small intestinal glucose on blood pressure and antropyloroduodenal motility in older subjects.
Gentilcore D; Little TJ; Feinle-Bisset C; Samsom M; Smout AJ; Horowitz M; Jones KL
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G692-8. PubMed ID: 17656445
[TBL] [Abstract][Full Text] [Related]
11. The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial.
Thazhath SS; Marathe CS; Wu T; Chang J; Khoo J; Kuo P; Checklin HL; Bound MJ; Rigda RS; Crouch B; Jones KL; Horowitz M; Rayner CK
Diabetes; 2016 Jan; 65(1):269-75. PubMed ID: 26470783
[TBL] [Abstract][Full Text] [Related]
12. Upper gastrointestinal responses to intraduodenal nutrient in type 1 diabetes mellitus.
Rayner CK; Schwartz MP; van Dam PS; Renooij W; de Smet M; Horowitz M; Wishart JM; Smout AJ; Samsom M
Eur J Gastroenterol Hepatol; 2004 Feb; 16(2):183-9. PubMed ID: 15075992
[TBL] [Abstract][Full Text] [Related]
13. Chemospecific alterations in duodenal perception and motor response in functional dyspepsia.
Schwartz MP; Samsom M; Smout AJ
Am J Gastroenterol; 2001 Sep; 96(9):2596-602. PubMed ID: 11569681
[TBL] [Abstract][Full Text] [Related]
14. [Effect of blood glucose control after small intestine exclusion surgery in Goto-Kakizaki rat with type 2 diabetes mellitus].
Wang Y; Zhang ZZ; Wang L; Deng ZZ; Jiao YB; Zou ZD
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2858-61. PubMed ID: 20137669
[TBL] [Abstract][Full Text] [Related]
15. Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men.
Pilichiewicz AN; Chaikomin R; Brennan IM; Wishart JM; Rayner CK; Jones KL; Smout AJ; Horowitz M; Feinle-Bisset C
Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E743-53. PubMed ID: 17609258
[TBL] [Abstract][Full Text] [Related]
16. Regional differences in the manifestation of gastrointestinal motor disorders in type 1 diabetic patients with autonomic neuropathy.
Rosztóczy A; Róka R; Várkonyi TT; Lengyel C; Izbéki F; Lonovics J; Wittmann T
Z Gastroenterol; 2004 Nov; 42(11):1295-300. PubMed ID: 15558439
[TBL] [Abstract][Full Text] [Related]
17. Small intestinal motor patterns in critically ill patients after major abdominal surgery.
Toumadre JP; Barclay M; Fraser R; Dent J; Young R; Berce M; Jury P; Fergusson L; Burnett J
Am J Gastroenterol; 2001 Aug; 96(8):2418-26. PubMed ID: 11513184
[TBL] [Abstract][Full Text] [Related]
18. The effects of critical illness on intestinal glucose sensing, transporters, and absorption.
Deane AM; Rayner CK; Keeshan A; Cvijanovic N; Marino Z; Nguyen NQ; Chia B; Summers MJ; Sim JA; van Beek T; Chapman MJ; Horowitz M; Young RL
Crit Care Med; 2014 Jan; 42(1):57-65. PubMed ID: 23963126
[TBL] [Abstract][Full Text] [Related]
19. Effect of the artificial sweetener, sucralose, on small intestinal glucose absorption in healthy human subjects.
Ma J; Chang J; Checklin HL; Young RL; Jones KL; Horowitz M; Rayner CK
Br J Nutr; 2010 Sep; 104(6):803-6. PubMed ID: 20420761
[TBL] [Abstract][Full Text] [Related]
20. Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes.
Wu T; Xie C; Wu H; Jones KL; Horowitz M; Rayner CK
Diabetes Obes Metab; 2017 Feb; 19(2):290-293. PubMed ID: 27761984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
